洞察市场格局
解锁药品研发情报

客服电话

400-9696-311
医药数据查询

【ChiCTR2000039984】Validation for hemoglobin screening using machine-learning approach with retinal characteristics

基本信息
登记号

ChiCTR2000039984

试验状态

正在进行

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2020-11-16

临床申请受理号

/

靶点

/

适应症

Hemoglobin level

试验通俗题目

Validation for hemoglobin screening using machine-learning approach with retinal characteristics

试验专业题目

Validation for hemoglobin screening using machine-learning approach with retinal characteristics

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

联系人通讯地址
请登录查看
临床试验信息
试验目的

1. To confirm the retinal image characteristics that significantly associated with anemia using machine-learning method; 2. To validate the final classification model for anemia based on a machine-learning approach as well as from specific set of retinal characteristics; 3.To compare the results of a fully automatic fundus camera (DRSPlus) to the current non-mydriatic fundus camera (CR2-AF) and evaluate the accuracy and efficiency for future potential.

试验分类
请登录查看
试验类型

连续入组

试验分期

其它

随机化

No

盲法

N/A

试验项目经费来源

N/A

试验范围

/

目标入组人数

1000

实际入组人数

/

第一例入组时间

2020-10-16

试验终止时间

2022-11-30

是否属于一致性

/

入选标准

1. Aged>18 years; 2. Willing to sign the inform consent; 3. Willing to comply with procedures required in the protocol; 4. Completed a fingerstick haemoglobin test.;

排除标准

1. Poor retinal images quality that cannot be used in the analysis; 2. Subjects with other eye diseases which are not suitable for retinal imaging, such as severe cataract, glaucoma, atretopsia, corneal plague; 3. Subjects are distress with flashlight or have experience with photosensitive seizure; 4. Unwillingness or inability to comply with procedures required in the protocol.;

研究者信息
研究负责人姓名
请登录查看
试验机构

The Centre for Clinical Research and Biostatistics, The Chinese University of Hong Kong

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

/

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

香港中文大學的其他临床试验

最新临床资讯

摩熵医药企业版
50亿+条医药数据随时查
7天免费试用